Zanamivir 10mg/ml solution for infusion pregnancy registry: an observational study of the safety of zanamivir 10mg/ml solution for infusion exposure in pregnant women with complicated influenza and their offspring (208140)

29/01/2020
30/09/2024
EU PAS number:
EUPAS33189
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

gsk-208140-protocol-redact

English (1.47 MB - PDF) View document
Updated protocol

gsk-208140-protocol-am1-redact

First published: 22/02/2024
English (298.48 KB - PDF) View document
Study results
Study report
Other information